NQO1 and gastric cancer: A retrospective study reported that NQO1 was overexpressed in gastric cancer and associated with poor prognosis, which demonstrates that NQO1 might be a promising biomarker in the prognostic evaluation for gastric cancer patients with adjuvant chemotherapy (1).